By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Drug Company to Congress: The ‘Dog Ate My Homework’
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Ethics > Drug Company to Congress: The ‘Dog Ate My Homework’
Medical Ethics

Drug Company to Congress: The ‘Dog Ate My Homework’

JohnCGoodman
JohnCGoodman
Share
2 Min Read
SHARE

Just about anyone who has ever been a kid in school recalls trying to make up an excuse believable enough to avoid being punished for not turning in your homework on time. An old favorite is “the dog ate my homework.”

Just about anyone who has ever been a kid in school recalls trying to make up an excuse believable enough to avoid being punished for not turning in your homework on time. An old favorite is “the dog ate my homework.”

A decade ago WilmerHale, a powerful law firm, missed a key deadline far more important than homework. It mistakenly filed a patent extension for its drug company client one day after the 60-day deadline. Rather than being penalized one letter grade like in grade school, the patent extension was rejected by the Patent and Trademark Office, causing the client to lose patent protection five years early for a drug it owned. The drug company sued its law firm, which agreed to cough up $214 million if it cannot somehow reverse the Patent Office’s extension rejection. The powerful law firm and its client have been lobbying Congress to change the law ever since.

In an amendment that is derisively being called “The Dog Ate My Homework Act,” the House agreed to change the way the 60-day patent extension filing deadline is calculated – just to benefit this one powerful law firm and its client. The Senate takes up the debate this week. If this amendment passes, consumers will pay more and have slower access to generic drugs. Let’s hope Congress leaves the law intact rather than demonstrate that rules can be broken when they are inconvenient to powerful lobbying interests.

More Read

5 Mistakes that Can Ruin a New Nurse’s Career
FDA Criticized for Lack of Controls over Increasing Prescription Narcotic Abuse
Demand For Synthetic Camphor Is About To Increase – Here’s Why
FDA Approvs for New Blood Thinner For Knee and Hip Replacements
Study Finds Nursing Homes Have Inadequate Care and Discharge Planning
   

TAGGED:pharmaceuticalsWilmerHale
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

post-surgical recovery
Your Guide To Key Milestones In At Home Post-Surgical Recovery
Health Infographics
December 14, 2025
Dehydration Poses Serious Risks For Older Adults
Why Dehydration Poses Serious Risks For Older Adults
Infographics Senior Care
December 14, 2025
care settings
Hidden Risks In Care Settings: Who Faces The Greatest Threat From Healthcare-Associated Infections
Global Healthcare Health care Infographics
December 14, 2025
Medical Appointment
From Scheduling To Follow-Up: The Full Lifecycle Of A Medical Appointment
Infographics Medical Education Policy & Law
December 14, 2025

You Might also Like

generic pharmaceuticals
Medical EthicsPolicy & LawPublic Health

Are Biosimilars Ethical?

May 16, 2013

Head of the DOJ’s Antitrust Division Raises Concerns About Two Proposed Mega-Mergers Between Leading Health Insurers

November 20, 2015

More On Why There Are Drug Shortages

August 10, 2011

The $78 Pill

October 10, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?